Rare Diseases Activities
Reviewing Clinical Therapy Advances and Management of Amyotrophic Lateral Sclerosis
0290-0000-19-097-H01-P
This program will examine the pathophysiology and degenerative effects of amyotrophic lateral sclerosis (ALS).
1.50
Novel Advances in Hereditary ATTR Amyloidosis: Payer and Specialty Pharmacy Considerations
0290-0000-19-103-H01-P
This program will analyze data supporting the use of current and emerging therapies for the treatment of hATTR.
1.50
Examining Therapy, Health Care Utilization, and Patient Management for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
0290-0000-19-098-H01-P
This program will identify the cost and pharmacy benefit implications of CIDP care coordination in inpatient and outpatient settings.
1.50
Analyzing Hereditary Angioedema: A Review of Evidence and Treatment Approaches
0290-0000-19-102-H01-P
This webinar will explain the efficacy of current and emerging treatment for prophylaxis of acute hereditary angioedema (HAE)
1.50